Key result
History as an endurance athlete predicted the need for a repeat ablation procedure due to VA recurrence in ARVC patients.
Why the study?
The reason for recurrence of ventricular arrhythmia after catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy was not clear.
Does history as an endurance athlete predict ventricular arrhythmia recurrence after catheter ablation in patients with ARVC?
Cohort (n=91)
Does history as an endurance athlete predict ventricular arrhythmia recurrence after catheter ablation in patients with ARVC?
In patients with ARVC undergoing catheter ablation for ventricular arrhythmias, a history as an endurance athlete strongly predicts arrhythmia recurrence and the need for repeat ablation due to scar progression.
Answers are grounded in this paper and cite their sources.
Endurance athlete history may identify ARVC patients needing closer post-ablation monitoring; leaves open whether activity restriction reduces recurrence.
BACKGROUND: The reason for recurrence of ventricular arrhythmia (VA) after catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) is not clear. METHODS: In this study, 91 ARVC patients (age, 47 ± 13 years; 47 men) who underwent catheter ablation for drug-refractory ventricular arrhythmia (VA) were enrolled. The patients were categorized into single or multiple procedures (n = 28). The baseline characteristics and electrophysiological features of the patients were examined to elucidate the reason of the VA recurrences. RESULTS: A total of 186 VAs were induced during the index procedure and 176 (94.6%) were eliminated. Successful, partially successful, and failed ablations were achieved in 89.0%, 8.8%, and 2.2% of the patients, respectively. During a mean follow-up period of 32 ± 26 months, 35 patients had VA recurrences. Forty-two repeat procedures were performed for 81 induced VAs in 28 patients. Of the 42 repeat procedures, successful, partially successful, and failed ablations were achieved in 37, 4, and 1 of the procedures, respectively. Most of the recurrent VAs (70 [72.9%]) originated from the newly-developed circuits owing to the scar progression. The patients with repeat procedure had worsening right ventricular remodeling. The multivariate analysis revealed that history as endurance athlete significantly predicted the need of a repeat procedure in spite of the initially successful endocardial/epicardial ablation and negative inducibility (hazard ratio: 3.014, 95% confidence interval: 1.493-6.084, P = 0.002). CONCLUSIONS: In spite of the initial complete VA elimination, history as an athlete was associated with scar progression, RV remodeling, and VA recurrences from the newly developed arrhythmogenic substrates/circuit in ARVC.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2019) conducted a cohort in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=91). Catheter ablation was evaluated on Need of a repeat procedure (HR 3.014, 95% CI 1.493-6.084, p=0.002). History as an endurance athlete predicted the need for a repeat ablation procedure due to VA recurrence in ARVC patients.
Synapse has enriched 10 related papers. Consider them for comparative context: